Arax Advisory Partners’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
11,719
+11,316
+2,808% +$217K ﹤0.01% 2016
2026
Q1
$6.99K Sell
403
-173
-30% -$3.48K ﹤0.01% 2638
2025
Q4
$11.4K Sell
576
-13,866
-96% -$249K ﹤0.01% 2402
2025
Q3
$252K Buy
+14,442
New +$214K ﹤0.01% 1157

Other funds holding ALHC

Arax Advisory Partners's ALHC Position: Q2 2026 in Review

Arax Advisory Partners increased its Alignment Healthcare (ALHC) stake by 2,808% in Q2 2026, buying an estimated $217K and bringing the position to 11,719 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Arax Advisory Partners first reported a position in ALHC in Q3 2025 and has held it in 4 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Arax Advisory Partners held 11,719 shares of Alignment Healthcare worth $279K as of Q2 2026.
  • Arax Advisory Partners bought 11,316 Alignment Healthcare shares in Q2 2026, an estimated $217K.
  • Alignment Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2016 holding.
  • Arax Advisory Partners first reported a position in Alignment Healthcare in Q3 2025 and has held it in 4 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.